at Investor's Business Daily (Thu, 6:03PM)
Illumina (ILMN) agrees to acquire Verinata Health, a provider of non-invasive tests for the...
Illumina (ILMN) agrees to acquire Verinata Health, a provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for $350M upfront and as much as $100M in milestone payments through 2015. Illumina expects the deal to dilute its EPS by $0.20 in 2013 and become accretive from next year. (PR)
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Investor's Business Daily (Wed, 2:35PM)
at Zacks.com (Wed, 9:30AM)
at Zacks.com (Wed, 8:35AM)
at Zacks.com (Jan 23, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs